(Q37058005)

18 August 2017

1 reference

title

Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction (English)

1 reference

18 August 2017

1 reference

3

Wayne J G Hellstrom

1 reference

18 August 2017

Serap Gur

1

1 reference

ORCID Public Data File 2021

Philip J. Kadowitz

series ordinal

2

object named as

Philip J Kadowitz

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

68

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

209-229

1 reference

Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00005

Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00005

RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00005

Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00005

Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00005

Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase

21 January 2018

1 reference

12 December 2020

Benign prostatic hyperplasia has precise meaning

1 reference

12 December 2020

Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu

1 reference

12 December 2020

Sexual dysfunction in the United States: prevalence and predictors

1 reference

12 December 2020

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

12 December 2020

Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate

1 reference

12 December 2020

Integrative control of the lower urinary tract: preclinical perspective

1 reference

12 December 2020

Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia

1 reference

12 December 2020

Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects

1 reference

12 December 2020

Benign prostatic hyperplasia: age-related tissue-remodeling

1 reference

12 December 2020

Involvement of nitric oxide and cyclic GMP in rabbit urethral relaxation

1 reference

12 December 2020

A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate

1 reference

12 December 2020

Prostatic intraepithelial neoplasia (PIN): Current concepts

1 reference

12 December 2020

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract

1 reference

12 December 2020

Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction

1 reference

12 December 2020

Effect of D-004, a lipid extract from the Cuban royal palm fruit, on in vitro and in vivo effects mediated by alpha-adrenoceptors in rats

1 reference

12 December 2020

The efficacy and safety of tadalafil: an update

1 reference

12 December 2020

Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance

1 reference

12 December 2020

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

1 reference

12 December 2020

Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice

1 reference

12 December 2020

Lower urinary tract symptoms and erectile dysfunction: epidemiology and treatment in the aging man.

1 reference

12 December 2020

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction

1 reference

12 December 2020

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

1 reference

12 December 2020

Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation

1 reference

12 December 2020

Nitric oxide activates glibenclamide-sensitive K+ channels in urinary bladder myocytes through a c-GMP-dependent mechanism

1 reference

12 December 2020

Phytotherapy for benign prostatic hyperplasia

1 reference

12 December 2020

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

1 reference

12 December 2020

Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide

1 reference

12 December 2020

Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

1 reference

12 December 2020

1 reference

12 December 2020

Comorbid LUTS and erectile dysfunction: optimizing their management

1 reference

12 December 2020

Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors.

1 reference

12 December 2020

Ca2+ sensitization in contraction of human bladder smooth muscle

1 reference

12 December 2020

1 reference

12 December 2020

Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis

1 reference

12 December 2020

Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells

1 reference

12 December 2020

Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells

1 reference

12 December 2020

Endothelial nitric oxide synthase gene therapy for erectile dysfunction

1 reference

12 December 2020

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

12 December 2020

Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction

1 reference

12 December 2020

1 reference

12 December 2020

Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms

1 reference

12 December 2020

Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence

1 reference

12 December 2020

Management of symptomatic BPH in France: who is treated and how?

1 reference

12 December 2020

Landmark studies impacting the medical management of benign prostatic hyperplasia

1 reference

12 December 2020

alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction.

1 reference

12 December 2020

Protection of urinary bladder function by grape suspension

1 reference

12 December 2020

Low-dose tadenan protects the rabbit bladder from bilateral ischemia/ reperfusion-induced contractile dysfunction

1 reference

12 December 2020

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

1 reference

12 December 2020

"Alphabet soup" and the prostate: LUTS, BPH, BPE, and BOO

1 reference

12 December 2020

The endocrinology and developmental biology of the prostate

1 reference

12 December 2020

Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.

1 reference

12 December 2020

The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

12 December 2020

Prostatism: nature of the symptoms

1 reference

12 December 2020

Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP?

1 reference

12 December 2020

Evaluation of the effect of endothelin-1 and characterization of the selective endothelin a receptor antagonist PD155080 in the prostate

1 reference

12 December 2020

Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms

1 reference

12 December 2020

D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats.

1 reference

12 December 2020

5alpha-reductase activity in the prostate

1 reference

12 December 2020

Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia

1 reference

12 December 2020

Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey"

1 reference

12 December 2020

In vitro functional responses of isolated normal human prostatic tissue to compounds interacting with the cyclic guanosine monophosphate pathway

1 reference

12 December 2020

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases in rabbit detrusor smooth muscle

1 reference

12 December 2020

Cholinergic innervation and function in the prostate gland

1 reference

12 December 2020

Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience

1 reference

12 December 2020

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride

1 reference

12 December 2020

Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology

1 reference

12 December 2020

RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction

1 reference

12 December 2020

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

1 reference

12 December 2020

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study

1 reference

12 December 2020

Cholinergic, adrenergic, and purinergic neuromuscular transmission

1 reference

12 December 2020

ED2: erectile dysfunction = endothelial dysfunction

1 reference

12 December 2020

A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia

1 reference

12 December 2020

Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum.

1 reference

12 December 2020

Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group

1 reference

12 December 2020

Erection and NO override the vasoconstrictive effect of alpha-adrenergic stimulation in the rat penile vasculature

1 reference

12 December 2020

Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder Neck

1 reference

12 December 2020

American Urological Association - 96th Annual Meeting. 2-7 June 2001, Anaheim, CA, USA.

1 reference

12 December 2020

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer

1 reference

12 December 2020

The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia

1 reference

12 December 2020

Reduction of endothelin-1 binding and inhibition of endothelin-1-mediated detrusor contraction by naftidrofuryl

1 reference

12 December 2020

Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.

1 reference

12 December 2020

Endothelin receptor in benign prostatic hyperplastic cells. Binding and functional studies

1 reference

12 December 2020

The male genitourinary sphincter mechanism in the dog

1 reference

12 December 2020

The Clinical Benefits of Dutasteride Treatment for LUTS and BPH

1 reference

12 December 2020

Relationship of Flow Rate with Symptoms, Quality of Life and Other Clinical Parameters in Patients with LUTS Suggestive of BPH

1 reference

12 December 2020

Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study

1 reference

12 December 2020

Effect of Pygeum africanum tadenan on micturition and prostate growth of the rat secondary to coadministered treatment and post-treatment with dihydrotestosterone

1 reference

12 December 2020

Erectile dysfunction and lower urinary tract symptoms secondary to BPH.

1 reference

12 December 2020

Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system

1 reference

12 December 2020

Inward current oscillation underlying tonic contraction caused via ETA receptors in pig detrusor smooth muscle

1 reference

12 December 2020

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

12 December 2020

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

1 reference

12 December 2020

Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview

1 reference

12 December 2020

Effect of nitric oxide donor and alpha1-receptor antagonist on proliferation/apoptosis of hyperplastic prostatic stromal cells in vitro

1 reference

12 December 2020

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor

1 reference

12 December 2020

Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicen

1 reference

12 December 2020

Impact of treatment of BPH on sexuality

1 reference

12 December 2020

Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function

1 reference

12 December 2020

Nitric oxide control of lower genitourinary tract functions: a review

1 reference

12 December 2020

Herbal medications in the treatment of benign prostatic hyperplasia (BPH)

1 reference

12 December 2020

Detrusor contraction--Focus on muscarinic receptors

1 reference

12 December 2020

Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago

1 reference

12 December 2020

Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate

1 reference

12 December 2020

Voiding dysfunction: definitions

1 reference

12 December 2020

Alpha-Blocker Therapy Can Be Withdrawn in the Majority of Men Following Initial Combination Therapy with the Dual 5α-Reductase Inhibitor Dutasteride

1 reference

12 December 2020

Observational multicentric trial performed with doxazosin: evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia

1 reference

12 December 2020

Benign prostatic hyperplasia: a progressive disease of aging men.

1 reference

12 December 2020

Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis

1 reference

12 December 2020

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

1 reference

12 December 2020

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group

1 reference

12 December 2020

A review of the L-arginine - nitric oxide - guanylate cyclase pathway as a mediator of lower urinary tract physiology and symptoms

1 reference

12 December 2020

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system

1 reference

12 December 2020

Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms

1 reference

12 December 2020

Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation

1 reference

12 December 2020

A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction

1 reference

12 December 2020

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

12 December 2020

Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction

1 reference

12 December 2020

Sildenafil influences lower urinary tract symptoms.

1 reference

12 December 2020

LU 302 872 and its racemate (LU 224 332) show balanced endothelin-A/B receptor affinity, high oral activity, and inhibit human prostate tissue contractions

1 reference

12 December 2020

LUTS, BPH, BPE, BPO: A Plea for the Logical Use of Correct Terms

1 reference

12 December 2020

The mediation of the canine prostatic secretion provoked by hypogastric nerve stimulation

1 reference

12 December 2020

Consensus statement: the role of prostate-specific antigen in managing the patient with benign prostatic hyperplasia

1 reference

12 December 2020

Anticholinergic drugs in patients with bladder outlet obstruction and lower urinary tract symptoms: A systematic review

1 reference

12 December 2020

10.2165/00003495-200868020-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1025665560

0 references

1 reference